Artificial Intelligence in Medication Adherence and Personalized Treatment Plans

Adherence to medication and personalized treatment constitute the cornerstones of effective chronic disease management, yet the realization of their intent remains challenged by patient-specific, therapeutic, and systemic barriers. Due to the advancing availability of big health data and computational techniques, AI has made its stride into the health scenario as a disruptive force. This review discusses a variety of AI-powered tools used to monitor and enhance medication adherence—smart pill bottles, ingestible sensors, wearables, mHealth apps, and predictive analytics—and their incorporation into real-time clinical decision-making. We further discuss AI's role in developing personalized treatment regimens based on genomic data, adaptive algorithms, and electronic health records (EHR). The ethics of these challenges, including data privacy, algorithmic bias, and accountability, are further elucidated, alongside issues of in-field implementation. Lastly, along with the topics mentioned earlier, the review talks about future ideas like explainable AI, federated learning, and closed-loop adherence systems, which could help make AI a key part of personalized, proactive, and fair healthcare.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-01
DOI
https://doi.org/10.5281/zenodo.15315404
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial Intelligence in Medication Adherence and Personalized Treatment Plans

Zenodo (CERN European Organization for Nuclear Research)
Atrial Fibrillation Management and Outcomes
article

Artificial Intelligence in Medication Adherence and Personalized Treatment Plans

article en

Abstract

Adherence to medication and personalized treatment constitute the cornerstones of effective chronic disease management, yet the realization of their intent remains challenged by patient-specific, therapeutic, and systemic barriers. Due to the advancing availability of big health data and computational techniques, AI has made its stride into the health scenario as a disruptive force. This review discusses a variety of AI-powered tools used to monitor and enhance medication adherence—smart pill bottles, ingestible sensors, wearables, mHealth apps, and predictive analytics—and their incorporation into real-time clinical decision-making. We further discuss AI's role in developing personalized treatment regimens based on genomic data, adaptive algorithms, and electronic health records (EHR). The ethics of these challenges, including data privacy, algorithmic bias, and accountability, are further elucidated, alongside issues of in-field implementation. Lastly, along with the topics mentioned earlier, the review talks about future ideas like explainable AI, federated learning, and closed-loop adherence systems, which could help make AI a key part of personalized, proactive, and fair healthcare.

Zenodo (CERN European Organization for Nuclear Research)
Peace, Justice and strong institutions
Openalex Percentile: Top 40%
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Artificial Intelligence in Medication Adherence and Personalized Treatment Plans · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS